These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

547 related articles for article (PubMed ID: 19013850)

  • 1. The human brain endothelial cell line hCMEC/D3 as a human blood-brain barrier model for drug transport studies.
    Poller B; Gutmann H; Krähenbühl S; Weksler B; Romero I; Couraud PO; Tuffin G; Drewe J; Huwyler J
    J Neurochem; 2008 Dec; 107(5):1358-68. PubMed ID: 19013850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of BCRP (ABCG2) and P-glycoprotein (ABCB1) by cytokines in a model of the human blood-brain barrier.
    Poller B; Drewe J; Krähenbühl S; Huwyler J; Gutmann H
    Cell Mol Neurobiol; 2010 Jan; 30(1):63-70. PubMed ID: 19629677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ABC and SLC transporter expression and proton oligopeptide transporter (POT) mediated permeation across the human blood--brain barrier cell line, hCMEC/D3 [corrected].
    Carl SM; Lindley DJ; Das D; Couraud PO; Weksler BB; Romero I; Mowery SA; Knipp GT
    Mol Pharm; 2010 Aug; 7(4):1057-68. PubMed ID: 20524699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and function of multidrug resistance transporters at the blood-brain barriers.
    Scherrmann JM
    Expert Opin Drug Metab Toxicol; 2005 Aug; 1(2):233-46. PubMed ID: 16922639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta amyloid effects on expression of multidrug efflux transporters in brain endothelial cells.
    Kania KD; Wijesuriya HC; Hladky SB; Barrand MA
    Brain Res; 2011 Oct; 1418():1-11. PubMed ID: 21920506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ABC transporter (P-gp/ABCB1, MRP1/ABCC1, BCRP/ABCG2) expression in the developing human CNS.
    Daood M; Tsai C; Ahdab-Barmada M; Watchko JF
    Neuropediatrics; 2008 Aug; 39(4):211-8. PubMed ID: 19165709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioluminescent imaging of drug efflux at the blood-brain barrier mediated by the transporter ABCG2.
    Bakhsheshian J; Wei BR; Chang KE; Shukla S; Ambudkar SV; Simpson RM; Gottesman MM; Hall MD
    Proc Natl Acad Sci U S A; 2013 Dec; 110(51):20801-6. PubMed ID: 24297888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transport of cryptotanshinone, a major active triterpenoid in Salvia miltiorrhiza Bunge widely used in the treatment of stroke and Alzheimer's disease, across the blood-brain barrier.
    Yu XY; Lin SG; Chen X; Zhou ZW; Liang J; Duan W; Chowbay B; Wen JY; Chan E; Cao J; Li CG; Zhou SF
    Curr Drug Metab; 2007 May; 8(4):365-78. PubMed ID: 17504224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in dipole membrane potential at the mouse blood-brain barrier enhance the transport of 99mTechnetium Sestamibi more than inhibiting Abcb1, Abcc1, or Abcg2.
    Cattelotte J; Tournier N; Rizzo-Padoin N; Schinkel AH; Scherrmann JM; Cisternino S
    J Neurochem; 2009 Feb; 108(3):767-75. PubMed ID: 19067785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorescent substrates for flow cytometric evaluation of efflux inhibition in ABCB1, ABCC1, and ABCG2 transporters.
    Strouse JJ; Ivnitski-Steele I; Waller A; Young SM; Perez D; Evangelisti AM; Ursu O; Bologa CG; Carter MB; Salas VM; Tegos G; Larson RS; Oprea TI; Edwards BS; Sklar LA
    Anal Biochem; 2013 Jun; 437(1):77-87. PubMed ID: 23470221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An electrically tight in vitro blood-brain barrier model displays net brain-to-blood efflux of substrates for the ABC transporters, P-gp, Bcrp and Mrp-1.
    Helms HC; Hersom M; Kuhlmann LB; Badolo L; Nielsen CU; Brodin B
    AAPS J; 2014 Sep; 16(5):1046-55. PubMed ID: 24934296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aryl hydrocarbon receptor regulates CYP1B1 but not ABCB1 and ABCG2 in hCMEC/D3 human cerebral microvascular endothelial cells after TCDD exposure.
    Jacob A; Potin S; Chapy H; Crete D; Glacial F; Ganeshamoorthy K; Couraud PO; Scherrmann JM; Declèves X
    Brain Res; 2015 Jul; 1613():27-36. PubMed ID: 25858487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterisation of the brain multidrug resistance protein (BMDP/ABCG2/BCRP) expressed at the blood-brain barrier.
    Eisenblätter T; Hüwel S; Galla HJ
    Brain Res; 2003 May; 971(2):221-31. PubMed ID: 12706238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dexamethasone increases expression and activity of multidrug resistance transporters at the rat blood-brain barrier.
    Narang VS; Fraga C; Kumar N; Shen J; Throm S; Stewart CF; Waters CM
    Am J Physiol Cell Physiol; 2008 Aug; 295(2):C440-50. PubMed ID: 18524938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of two efflux proteins, ABCB1 and ABCG2 in blood-brain barrier transport of bromocriptine in a murine model of MPTP-induced dopaminergic degeneration.
    Vautier S; Milane A; Fernandez C; Chacun H; Lacomblez L; Farinotti R
    J Pharm Pharm Sci; 2009; 12(2):199-208. PubMed ID: 19732497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression, up-regulation, and transport activity of the multidrug-resistance protein Abcg2 at the mouse blood-brain barrier.
    Cisternino S; Mercier C; Bourasset F; Roux F; Scherrmann JM
    Cancer Res; 2004 May; 64(9):3296-301. PubMed ID: 15126373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered glycaemia differentially modulates efflux transporter expression and activity in hCMEC/D3 cell line.
    Sajja RK; Cucullo L
    Neurosci Lett; 2015 Jun; 598():59-65. PubMed ID: 25982326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterisation of the roles of ABCB1, ABCC1, ABCC2 and ABCG2 in the transport and pharmacokinetics of actinomycin D in vitro and in vivo.
    Hill CR; Jamieson D; Thomas HD; Brown CD; Boddy AV; Veal GJ
    Biochem Pharmacol; 2013 Jan; 85(1):29-37. PubMed ID: 23063411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PET-CT imaging with [(18)F]-gefitinib to measure Abcb1a/1b (P-gp) and Abcg2 (Bcrp1) mediated drug-drug interactions at the murine blood-brain barrier.
    Vlaming ML; Läppchen T; Jansen HT; Kivits S; van Driel A; van de Steeg E; van der Hoorn JW; Sio CF; Steinbach OC; DeGroot J
    Nucl Med Biol; 2015 Nov; 42(11):833-41. PubMed ID: 26264927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Zn
    Zaremba A; Helm F; Fricker G
    Mol Pharm; 2019 Jan; 16(1):305-317. PubMed ID: 30422662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.